Frédéric MARMION

Frédéric Marmion has diverse work experience spanning over three decades. Frédéric'smost recent role is as a Senior Clinical Project Manager at Inotrem SA, a biotechnology company specializing in immunotherapy for inflammatory syndromes. Prior to this, from 2018 to 2020, Marmion worked as the Responsable du développement clinique at OTR3, an innovative company in the field of regenerative medicine.

From 2006 to 2018, they were a Chef de Projet sénior en cancérologie at ARCAGY, where they managed national and international projects in ovarian and breast cancer. In 2005, Marmion served as a Chef de Projet sénior en cardiologie at Pfizer, overseeing a portfolio of cardiovascular projects.

Before that, they held the position of Chef de projet junior at 3M Pharmaceuticals from 2003 to 2005, and prior to that, they worked as an ARC at Astra Zeneca in 2001-2002.

In the earlier years of their career, Marmion gained experience as an ARC (APHP) at DRC APHP from 1998 to 2000, and as a Technicien de recherche at Guerbet from 1992 to 1998. Frédéric started their professional journey in 1991 with a full-time role at the blood bank of HIA Begin during their military service, where they were involved in blood transfusions and blood grouping.

Frédéric Marmion attended Lycée Jean Jaures Montreuil from 1988 to 1991, where they obtained their Bac degree. Following this, they pursued studies in Biologie at ESTBA from 1990 to 1992.